Abiopharma

Clinical trial NCT07361445: enrollment: 20 → 60 participants.

Clinical trial NCT07221981: enrollment: 1519 → 1708 participants.

Clinical trial NCT04624230 updates: 1. completion date: 2029-07-18 → 2029-07-04 2. primary completion date: 2027-04-28 → 2027-04-14

Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound

Clinical trial NCT06847867: intervention model: SEQUENTIAL → PARALLEL.

Clinical trial NCT04527991: enrollment: 712 → 711 participants.

Clinical trial NCT05077774 updates: 1. enrollment: 150 → 174 participants 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07483567 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-03-30 → 2026-04-17

Clinical trial NCT04468360 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2026-12-01 → 2025-04-29 3. primary completion date: 2026-12-01 → 2025-04-29 4. enrollment: 256 → 11 participants 5. enrollment type: ESTIMATED → ACTUAL 6. allocation: RANDOMIZED → NON_RANDOMIZED 7. intervention model: PARALLEL → SEQUENTIAL 8. primary purpose: BASIC_SCIENCE → …

Clinical trial NCT05709158 updates: 1. status: UNKNOWN → COMPLETED 2. start date: 2024-03-01 → 2024-08-19 3. completion date: 2024-04-30 → 2024-08-30 4. primary completion date: 2024-04-30 → 2024-08-30 5. enrollment: 1300 → 4184 participants 6. enrollment type: ESTIMATED → ACTUAL